Literature DB >> 16234247

Evidence that the 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD1) is regulated by pentose pathway flux. Studies in rat adipocytes and microsomes.

Kenneth L McCormick1, Xudong Wang, Gail J Mick.   

Abstract

11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1) catalyzes the interconversion of biologically inactive 11 keto derivatives (cortisone, 11-dehydrocorticosterone) to active glucocorticoids (cortisol, corticosterone) in fat, liver, and other tissues. It is located in the intraluminal compartment of the endoplasmic reticulum. Inasmuch as an oxo-reductase requires NADPH, we reasoned that 11 beta-HSD1 would be metabolically interconnected with the cytosolic pentose pathway because this pathway is the primary producer of reduced cellular pyridine nucleotides. To test this theory, 11 beta-HSD1 activity and pentose pathway were simultaneously measured in isolated intact rodent adipocytes. Established inhibitors of NAPDH production via the pentose pathway (dehydroandrostenedione or norepinephrine) inhibited 11 beta-HSD1 oxo-reductase while decreasing cellular NADPH content. Conversely these compounds slightly augmented the reverse, or dehydrogenase, reaction of 11 beta-HSD1. Importantly, using isolated intact microsomes, the inhibitors did not directly alter the tandem microsomal 11 beta-HSD1 and hexose-6-phosphate dehydrogenase enzyme unit. Metabolites of 11 beta-HSD1 (corticosterone or 11-dehydrocorticosterone) inhibited or increased pentose flux, respectively, demonstrating metabolic interconnectivity. Using isolated intact liver or fat microsomes, glucose-6 phosphate stimulated 11 beta-HSD1 oxo-reductase, and this effect was blocked by selective inhibitors of glucose-6-phosphate transport. In summary, we have demonstrated a metabolic interconnection between pentose pathway and 11 beta-HSD1 oxo-reductase activities that is dependent on cytosolic NADPH production. These observations link cytosolic carbohydrate flux with paracrine glucocorticoid formation. The clinical relevance of these findings may be germane to the regulation of paracrine glucocorticoid formation in disturbed nutritional states such as obesity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16234247     DOI: 10.1074/jbc.M506026200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  20 in total

1.  Contribution of hexose-6-phosphate dehydrogenase to NADPH content and redox environment in the endoplasmic reticulum.

Authors:  Daniela Rogoff; Kelli Black; D Randy McMillan; Perrin C White
Journal:  Redox Rep       Date:  2010       Impact factor: 4.412

2.  Global metabolic effects of glycerol kinase overexpression in rat hepatoma cells.

Authors:  Ganesh Sriram; Lola Rahib; Jian-Sen He; Allison E Campos; Lilly S Parr; James C Liao; Katrina M Dipple
Journal:  Mol Genet Metab       Date:  2007-10-29       Impact factor: 4.797

Review 3.  The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders.

Authors:  Walter L Miller; Richard J Auchus
Journal:  Endocr Rev       Date:  2010-11-04       Impact factor: 19.871

4.  Tissue-specific dysregulation of hexose-6-phosphate dehydrogenase and glucose-6-phosphate transporter production in db/db mice as a model of type 2 diabetes.

Authors:  Y Wang; Y Nakagawa; L Liu; W Wang; X Ren; A Anghel; K Lutfy; T C Friedman; Y Liu
Journal:  Diabetologia       Date:  2010-11-04       Impact factor: 10.122

Review 5.  Hexose 6-phosphate dehydrogenase (H6PD) and corticosteroid metabolism.

Authors:  Perrin C White; Daniela Rogoff; D Randy McMillan; Gareth G Lavery
Journal:  Mol Cell Endocrinol       Date:  2007-01-19       Impact factor: 4.102

6.  Transgenic overexpression of hexose-6-phosphate dehydrogenase in adipose tissue causes local glucocorticoid amplification and lipolysis in male mice.

Authors:  Ying Wang; Limei Liu; Hanze Du; Yoshiko Nagaoka; Winnie Fan; Kabirullah Lutfy; Theodore C Friedman; Meisheng Jiang; Yanjun Liu
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-12-31       Impact factor: 4.310

7.  Direct regulation of glucose and not insulin on hepatic hexose-6-phosphate dehydrogenase and 11β-hydroxysteroid dehydrogenase type 1.

Authors:  Zheng Fan; Hongwei Du; Ming Zhang; Zhaojie Meng; Li Chen; Yanjun Liu
Journal:  Mol Cell Endocrinol       Date:  2010-12-14       Impact factor: 4.102

8.  Continuous inhibition of 11β-hydroxysteroid dehydrogenase type I in adipose tissue leads to tachyphylaxis in humans and rats but not in mice.

Authors:  P Morentin Gutierrez; A Gyte; J deSchoolmeester; P Ceuppens; J Swales; C Stacey; J W Eriksson; M Sjöstrand; C Nilsson; B Leighton
Journal:  Br J Pharmacol       Date:  2015-10-08       Impact factor: 8.739

9.  Reduction of hepatic glucocorticoid receptor and hexose-6-phosphate dehydrogenase expression ameliorates diet-induced obesity and insulin resistance in mice.

Authors:  Yanjun Liu; Yuichi Nakagawa; Ying Wang; Limei Liu; Hongwei Du; Wei Wang; Xiuhai Ren; Kabirullah Lutfy; Theodore C Friedman
Journal:  J Mol Endocrinol       Date:  2008-06-04       Impact factor: 5.098

10.  A putative hydroxysteroid dehydrogenase involved in regulating plant growth and development.

Authors:  Fengling Li; Tadao Asami; Xianzhong Wu; Edward W T Tsang; Adrian J Cutler
Journal:  Plant Physiol       Date:  2007-07-06       Impact factor: 8.340

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.